BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15583697)

  • 1. Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.
    Zhang GY; Ahmed N; Riley C; Oliva K; Barker G; Quinn MA; Rice GE
    Br J Cancer; 2005 Jan; 92(1):113-9. PubMed ID: 15583697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.
    Ahmed N; Riley C; Quinn MA
    Br J Cancer; 2008 Apr; 98(8):1415-24. PubMed ID: 18349831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
    Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
    J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of TLR9 in ovarian cancer].
    Sha HL; Ouyang WX; Lü G
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):913-6. PubMed ID: 21223799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
    Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
    Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.
    Sakamoto A; Yokoyama Y; Umemoto M; Futagami M; Sakamoto T; Bing X; Mizunuma H
    Br J Cancer; 2004 Aug; 91(4):633-8. PubMed ID: 15266333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTF-1 expression in primary ovarian epithelial neoplasia.
    Graham AD; Williams AR; Salter DM
    Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ; Qiao YH; Suo ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis.
    Määttä M; Bützow R; Luostarinen J; Petäjäniemi N; Pihlajaniemi T; Salo S; Miyazaki K; Autio-Harmainen H; Virtanen I
    J Histochem Cytochem; 2005 Oct; 53(10):1293-300. PubMed ID: 15923364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammaglobin expression in gynecologic adenocarcinomas.
    Hagemann IS; Pfeifer JD; Cao D
    Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma.
    Khin EE; Kikkawa F; Ino K; Suzuki T; Shibata K; Kajiyama H; Tamakoshi K; Mizutani S
    Int J Gynecol Pathol; 2003 Apr; 22(2):175-80. PubMed ID: 12649673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression.
    Sundfeldt K; Ivarsson K; Carlsson M; Enerbäck S; Janson PO; Brännström M; Hedin L
    Br J Cancer; 1999 Mar; 79(7-8):1240-8. PubMed ID: 10098766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.